Form 4 for CYTK CYTOKINETICS INC
Accepted 2021-12-23 00:00:00 ET · period of report 2021-12-23 · accession 0001061983-21-000265 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-23 | 2021-12-23 | CYTK | Kaye Edward M. MD | Dir | M - OptEx | $7.61 | +15.0K | 21.8K | +222% | +$114.2K |
| D | 2021-12-23 | 2021-12-23 | CYTK | Kaye Edward M. MD | Dir | S - Sale+OE | $45.00 | -15.0K | 6,765 | -69% | -$675.0K |
| D | 2021-12-23 | 2021-12-23 | CYTK | Kaye Edward M. MD | Dir | M - OptEx | $0.00 | -15.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-23 | M | A | 15,000 | $7.61 | 21,765 | D | — | — | (F2) Amount includes 1,765 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. |
| 2 | Common | Common Stock | 2021-12-23 | S | D | 15,000 | $45.00 | 6,765 | D | — | — | (F2) Amount includes 1,765 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. |
| 3 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-12-23 | M | D | 15,000 | $0.00 | 0 | D | $7.61 · 2016-06-18 to 2026-05-18 | 15,000 Common Stock |